Fyavolv

Fyavolv ingredients

Fyavolv is used as part of menopausal hormone therapy and has as active ingredients: Ethinyl Estradiol (synthetic form of estrogen) and Norethindrone (synthetic form of progesterone).
Ethinyl estradiol helps alleviate menopausal symptoms by replacing the declining levels of natural estrogen in the body.

Norethindrone is added to protect the uterus lining from the potential risks of estrogen therapy alone. Together, they provide relief from menopausal symptoms and support overall hormonal balance.

Fyavolv Side Effects

Common side effects include:

• Breast tenderness or enlargement: Estrogen can cause breast tissue to become tender or swollen. This side effect usually resolves on its own after a few weeks or months as your body gets used to the medication. If this continues or increases, you should talk with your healthcare provider.
• Headaches: Some women may experience headaches while taking hormone replacement therapy. In most cases, these headaches are mild and go away on their own. If they are associated with visual changes or neurological signs such as numbness, tingling or one-sided weakness, you should talk with your in-person healthcare provider immediately and call 911 if you are having an emergency.
• Nausea: Fyavolv can cause nausea, especially when starting the treatment. Taking the medication with food or at bedtime may help alleviate this side effect.
• Vaginal bleeding: Fyavolv can cause irregular bleeding or spotting, especially during the first few months of treatment. This side effect should be reported to your healthcare provider.
• Mood changes: Some women may experience mood swings, irritability, or changes in libido while on hormone replacement therapy. These effects are usually temporary and resolve with time.
• Fluid retention: Fyavolv can cause fluid retention, leading to bloating or weight gain. This side effect is usually mild and temporary.
• Increased risk of blood clots: Estrogen and progestin can increase the risk of developing blood clots, which can lead to deep vein thrombosis (DVT) or pulmonary embolism (PE). It is important to discuss your individual risk factors with your healthcare provider before starting hormone replacement therapy.
• Increased risk of certain cancers: Long-term use of Fyavolv as part of hormone replacement therapy may slightly increase the risk of breast cancer, ovarian cancer, and endometrial cancer. However, the overall risk is still relatively low.

Serious side effects including heart attack and stroke are rare but can include an increased risk of blood clots, stroke, heart attack, and certain types of cancer. Contact your doctor immediately if you experience:

• Jaw or shoulder pain, chest pain or pressure, nausea, sweating
• Slurred speech, sudden numbness or weakness (especially on one side of the body), sudden severe headache, problems with vision or balance
• Stabbing chest pain, sudden vision loss, feeling short of breath, coughing up blood, pain or warmth in one or both legs
• Swelling or tenderness in your stomach
• Yellowing of the skin or eyes (jaundice)
• Unusual behavior, memory problems, confusion
• Pelvic pain, unusual vaginal bleeding
• Unusual vaginal bleeding
• A lump in your breast

It is important to note that the benefits of hormone replacement therapy in managing menopausal symptoms often outweigh the potential risks. However, each individual’s situation is unique, and it is important to discuss the potential risks and benefits with your healthcare provider before starting any medication.

Fyavolv Benefits

The benefits of Fyavolv combination pills used in hormone replacement therapy for menopause symptoms may include:

• Relief from vasomotor symptoms (hot flashes and night sweats): Fyavolv can help reduce the frequency and severity of hot flashes and night sweats, which are common symptoms of menopause.
• Improved vaginal health: Fyavolv can help alleviate vaginal dryness, itching, and discomfort, making sexual intercourse more comfortable.
• Prevention of bone loss: Fyavolv can help slow down or prevent bone loss, reducing the risk of postmenopausal osteoporosis and fractures associated with menopause.
• Improved mood and well-being: Fyavolv may help improve mood swings, irritability, and anxiety that can occur during menopause.
• Protection against heart disease: Fyavolv may provide some protection against heart disease, especially if initiated early after menopause but these benefits are, as yet, unproven

Fyavolv Contraindications

There are certain contraindications or situations where the use of Fyavolv may not be recommended.

• Allergy to Ethinyl Estradiol and Norethindrone or any of the medication ingredients.
• Known or suspected pregnancy: Fyavolv should not be used if a woman is pregnant or suspects she may be pregnant. This medication, in menopausal doses, can not be used for birth control so there may still be a risk of pregnancy. Speak with your healthcare provider about whether you need reliable contraception.
• History of blood clots: Women with a history of blood clots in the legs (deep vein thrombosis) or lungs (pulmonary embolism) should avoid using Fyavolv. This medication can increase the risk of blood clot formation, which can be life-threatening.
• History of heart attack or stroke: Women with a history of heart attack or stroke should generally avoid using Fyavolv. The medication can increase the risk of cardiovascular events in individuals with a history of these conditions.
• Liver disease: Severe liver disease or liver tumors are contraindications for the use of all hormones, including ethinyl estradiol and norethindrone. Those can be metabolized in the liver, and liver dysfunction can affect their clearance from the body and increase the risk of adverse effects.
• Uncontrolled high blood pressure: Women with uncontrolled high blood pressure should be cautious when using Fyavolv. This medication can increase blood pressure, and individuals with pre-existing hypertension may experience further elevation of blood pressure.
• Breast cancer or other hormone-sensitive cancers: Women with a history of breast cancer or other hormone-sensitive cancers should generally avoid using estrogen and progesterone hormones containing medications. These medications can potentially stimulate the growth of hormone-sensitive tumors.

It is important to note that these are general contraindications, and individual patient factors and medical history should be considered when determining the appropriateness of using Fyavolv. It is always recommended to consult with a healthcare professional for personalized advice.

Fyavolv Dosage

• Fyavolv 0.5mg/2.5mcg $121 - In Stock
• Fyavolv 1mg/5mcg $95 - In Stock